• +971 0000 000 000
  • info@verticaljournal.top

Class Action Lawsuit Filed Against Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Grand News Network | November 6, 2023

ATLANTA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Outlook Therapeutics, Inc. ("Outlook Therapeutics" or "the Company") (NASDAQ:OTLK). The lawsuit alleges Outlook Therapeutics made false or misleading statements and/or omitted material adverse information regarding the Company's business, operations, and prospects, including: (i) there was a lack of substantial evidence supporting ONS-5010 as a treatment for wet AMD; (ii) the Company and/or its manufacturing partner had deficient chemistry manufacturing and controls ("CMC") and other manufacturing issues for ONS-5010, which remained unresolved at the time the ONS-5010 BLA was resubmitted ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner